Gane E. Safety and Efficacy at 1 year after Switching from Tenofovir Disoproxil Fumurate to Tenofovir Alafenamide in Chronic HBV Patients with Risk Factors for TDF Use. PS-156.
Intranasaal vaccin induceert lokale en systemische immuniteit tegen RSV
aug 2019 | Vaccinatie, Virale infecties